Our Company                   

Staff

Investigators

Current Trials

Prior Trials

HIPAA

Home

 

PAUL BROWNSTONE, MD

CURRICULUM VITAE

Present Employment:

Medical Director - Alpine Clinical Research Center
January 1998 - present

Previous Employment:

Private Practice - Associated Neurologists, PC  
Boulder, CO                    
August 1991 - Jan. 1998                                                                                
Private Practice - Clinical Neurology  
Long Beach, CA                                          
1984 - 1991

Education:

Northwestern University             
Evanston, Illinois
Honors Program in Medical Education (6 year medical program)

B.S. in Medicine with Highest Distinction, 1978

M.D. with Distinction, 1979

Residency:

Evanston Hospital               
Northwestern University    
Evanston, Illinois        
Internship in Internal Medicine, 1980

U.C.L.A. Center for Health Sciences   
University of California      
Los Angeles, California   
Residency in Neurology, 1981-1984

Certifications and Licenses:

Board Certified In Neurology              
American Board of Psychiatry and Neurology, 1986

Certificate of Added Qualifications in Clinical Neurophysiology American Board of Psychiatry & Neurology, 1996

American Society of Neurorehabilitation    
Certified Member, 1992

Colorado Medical License #30904
Granted July, 1991

California Medical License #G44018     
Granted January, 1981

Academic Position:

Assistant Clinical Professor   
Department of Neurology  
UCLA and Neuropsychiatric Institute   
Los Angeles, California, 1984-1991

Clinical Instructor            
Department of Neurology      
University of Colorado Health Sciences Center
Denver, Colorado, 1996 - 1997

Honors:

Alpha Omega Alpha Honorary Medical Society
1978 to present

Augustus Rose Award for Best Teaching Resident in Neurology at UCLA, 1984

Memberships:

American Academy of Neurology   
Active Membership, 1982 to present  

Publications:

Bilateral Superior Laryngeal Neuralgia -Its Successful Treatment with Carbamazepine.  
Arch Neurol 37:525, 1980, Brownstone, PK, et al.

Atypical Brainstem Encephalitis - Magnetic Resonance Imaging and Oculographic Features.   
Neurology 35: 438-440, 1985. Furman, JM, Brownstone, PK, Baloh, RW

Two Gay Patients with Demyelinating Disorders.
Hospital Practice, 1986. Asbill, MC, Marmarelis, PZ, and Brownstone, PK

Hospitals:

Boulder Community Hospital    
1100 Balsam, Boulder, CO 80304      
Active Staff, 1991-Present

RESEARCH:

Completed "Human Participants Protection Education for Research Teams" sponsored by NIH, June 2004 and March 2001

Completed course "Good Clinical Practices for Clinical Investigators" (18.5 credit hours) sponsored by Eli Lilly,   October 2001

Chairman-Institutional Review Board
Boulder Community Hospital, 2001-2003

RESEARCH EXPERIENCE:

Sponsor                      Indication\Year

SmithKline Beecham    Alzheimers Phase II, 1995

Ciba Geigy               Acute Ischemic Stroke, 1995

Glaxo                            Migraine Headache, 1995

Glaxo S2WA3012        Adolescent   Migraine, 1996

Glaxo S2WA1007           Migraine Headache, 1996

Janssen 16                   Migraine Headache, 1996

Boehringer Ingelheim Acute Ischemic Stroke, 1996

SmithKline Beecham      Alzheimers, 1996

Janssen 17                   Migraine Headache, 1997

Janssen 18                   Migraine Headache, 1997

Zeneca                        Migraine Headache, 1997

Vanguard                     Migraine Headache, 1997

TAP                             Heartburn, 1997

Wyeth-Ayerst           Acute Ischemic Stroke, 1997

Gilead Sciences             Influenza, 1997

TAP                             Sinusitis, 1997

TAP                             Pharyngitis, 1997

Glaxo 4002       Migraine Headache, 1997-1998

Glaxo 3005              Adolescent Migraine, 1998

Glaxo 3006              Adolescent Migraine, 1998

Glaxo CIA2001              Migraine Headache, 1998

Novartis                Hypercholesterolemia, 1998

Novartis                      Hypertension, 1998

Boehringer Ingelheim    Hypertension, 1998

Merck KGaA                 Depression, 1998

Merck                         Complicated UTI, 1998

Glaxo                         Bipolar Depression, 1999

Roche                         Influenza, 1999

Parke Davis                 Chronic Low Back Pain, 1999

Roxanne                     Chronic Pain, 1999

SKB                             PTSD, 1999

Pharmacia Upjohn        Depression, 2000

TAP                             Impotence, 2000

Parke Davis                 Post Herpetic Neuralgia, 2000

Glaxo                         Herpes Labialis, 2000

RW Johnson                 Influenza, 2000

Glaxo                           Menstrual Migraine, 2000

Ares-Serono                 Multiple Sclerosis, 2000

Smith Klein         Pre-Menstrual Dysphoric Disorder, 2000

Glaxo Wellcome         Adolescent Migraine, 2000

Glaxo Wellcome         Adult Migraine, 2000

Viropharma                URI, 2000

Pfizer                        Post Herpetic Neuralgia, 2000

3M                            Recurrent Genital Herpes, 2001

Astra Zenica               Acute Deep Venous Thrombosis, 2001

Eli Lilly                     Stress Urinary Incontinence, 2001

UCB                         Diabetic Neuropathy, 2001

Alpha Research           Parkinson's Disease, 2001

Janssen                    Vascular Dementia, 2001

Bayer                         Uncomplicated UTI, 2002

Allergan                     Psoriasis, 2002

Biocryst                     Influenza, 2002

Pfizer               Painful Diabetic Neuropathy, 2002

Pfizer                         Osteoarthritis, 2002

Abbott                       Urokinase, 2002

Ares-Serono                Multiple Sclerosis, 2002

Glaxo                        Adolescent Migraine, 2002

Glaxo                        Adult Migraine, 2002

Bayer                        Complicated UTI, 2002

Glaxo              Painful Diabetic Neuropathy, 2002

Glaxo                    Post Herpetic Neuralgia, 2002

Wyeth                URI, 2003

Berlex                PMS, 2003

AVI                    West Nile Virus, 2003

Kadmus              Post Herpetic Neuralgia, 2003

Takeda               Chronic Insomnia, 2003

Pfizer                Diabetic Neuropathy, 2003

Pfizer                Post Herpetic Neuralgia, 2003

Glaxo                Adult Migraine, 2003

Serono            Multiple Sclerosis, 2003

Glaxo                Parkinson's, 2004

Allergan            Post Herpetic Neuralgia, 2004

Forest               Post Herpetic Neuralgia, 2004

Wyeth            Diabetic Neuropathy, 2004

Abbott            Multiple Sclerosis, 2004

Glaxo            Adult Migraine, 2004

NIH                Multiple Sclerosis, 2004

Merck            Adult Migraine, 2004

Takeda            Insomnia, 2005

Kadmus        Post Herpetic Neuralgia, 2005

Glaxo            Adult Migraine, 2005

Pfizer            Painful Diabetic Neuropathy, 2005

NeurogesX    Post Herpetic Neuralgia, 2005

AVI            Hepatitis C-Phase 1, 2005

Astellas        Painful Diabetic Neuropathy, 2005

Merck KgAA    Parkinson's Disease, 2005

Predix            Hypoxic Challenge,Phase 1, 2006

Pfizer            Low Back Pain, 2006

Pfizer            Post Herpetic Neuralgia, 2006

Serono        Multiple Sclerosis, 2006

Novartis        Pediatric ADD/ADHD, 2006

Pfizer            Low Back Pain, 2006

J&J                Diabetic Peripheral Neuropathy, 2007

Eisai               Diabetic Peripheral Neuropathy, 2007

Eisai                Post Herpetic Neuralgia, 2007

Schwartz        Migraine, 2007

Allergan            Migraine Prophylaxis, 2007

Serono            Multiple Sclerosis, 2007

St. Jude        PFO Closure/Migraine, 2007

GSK                Post Herpetic Neuralgia, 2008

Elan                Alzheimer's Disease, 2008

Eli Lilly            Neuropathic Pain, 2008

Biocryst        Influenza, 2009

Forest            Diabetic Peripheral Neuropathy, 2009

 Contact me by E-Mail:  Paul Brownstone, MD

Rev. 3/09